Abstract:Background Accelerometers and patient-reported outcomes (PRO) are used to assess physical activity (PA) in people with multiple sclerosis (pwMS). So far it is unknown, however, whether these assessments represent mobility limitations in pwMS with mild and moderate to severe disability alike. The primary aim of the study was to assess the correlation between accelerometry and International Physical Activity Questionnaire (IPAQ) scores in pwMS with different degrees of ambulatory impairment. Taken its frequent use into account, the Godin Leisure Time Exercise Questionnaire (GLTEQ) was investigated as additional PRO. Methods In a prospective cohort of pwMS, correlational analyses were performed between the number of daily steps, time spent in light, moderate to vigorous PA (MVPA) and time spent sitting as assessed using accelerometry (ActiGraph®-GT3X), and the respective IPAQ and GLTEQ scores. Additionally, associations of PA with disease-specific characteristics, aerobic capacity (VO2 peak ), walking assessments (Timed 25-Foot Walk, T25FW; 2-Minute Walk Test, 2MWT) and walking perception (Multiple Sclerosis Walking Scale-12; MSWS-12) were explored. Patient subgroups with mild (Expanded Disability Status Scale; EDSS score <4.0) and moderate to severe disability (EDSS ≥4.0) were analysed for the impact of ambulatory impairment on PA. Multiple linear regression was used to determine predictors of PA. Results A total of 56 pwMS completed the study, with a mean (standard deviation, SD) age of 48.4 (10.3) years, disease duration of 14.8 (9.6) years and median (interquartile range) EDSS score of 3.5 (2.0 – 4.4). Moderate to weak correlations were found between daily step count and IPAQ total metabolic equivalent (MET) minutes/week (p<0.001; r=0.506), MVPA MET-minutes/week (p<0.01; r=0.479) and walking MET-minutes/week (p<0.05; r=0.372) in the total cohort. Time spent sitting was inversely correlated with total MET-minutes/week and MVPA MET-minutes/week (p<0.05; r= -0.358 and r= -0.365). Subgroup analysis revealed, that daily step count was significantly correlated with total MET-minutes/week, MVPA MET-minutes/week and walking MET-minutes/week (p<0.01, r=0.569; p<0.01, r=0.531 and p<0.05, r=0.480 respectively) in the "mild disability" subgroup only, whereas time spent sitting was inversely correlated with total MET-minutes/week (p<0.05; r= -0.582) in the "moderate to severe disability" subgroup. There was no association between objectively assessed PA and GLTEQ scores in any group. In the total cohort, moderate to weak correlations were found between daily step count and walking assessments (T25FW: p<0.01, ρ= -0.508; 2MWT: p<0.01, ρ=0.463) and MSWS-12 (p<0.001; ρ= -0.609). Moderate to weak correlations were also observed between VO2 peak and walking assessments (T25FW: p<0.01; ρ= -0.516; 2MWT: p<0.01, ρ=0.480). Multiple linear regression analysis identified disability and VO2 peak as predictors of PA (p=0.045; β=0.25 and p<0.001; β=0.49). Conclusion Significant associations of objective PA measurements using accelerometry with IPAQ were found only in pwMS with "mild disability". In pwMS with "moderate to severe disability", IPAQ did not reflect the objectively assessed amount of PA. In our cohort, GLTEQ showed no association with objectively assessed PA. Thus, an MS-specific self-reported questionnaire for assessing PA is warranted.

Free-living ambulatory physical activity and cognitive function in multiple sclerosis: the significance of step rate vs. step volume

Salicylates in rheumatoid arthritis: pharmacokinetics and analgesic response.

Remote Actigraphy for Quantitative Assessment of Walking Speed in People with MS (P3.309)

Rely on data, not politics, when redesigning schedule.

Making Every Step Count: Minute-by-Minute Characterization of Step Counts Augments Remote Activity Monitoring in People With Multiple Sclerosis

Cardiorespiratory fitness and free-living physical activity are not associated with cognition in persons with progressive multiple sclerosis: Baseline analyses from the CogEx study

Physical Activity and Cognitive Function in Mild Cognitive Impairment

Predicting physical activity for people with multiple sclerosis: The role of exercise-related cognitive errors.

The relationship between physical activity and symptoms of fatigue, mood, and perceived cognitive impairment in adults with multiple sclerosis

Association of Accelerometer-Measured Light-Intensity Physical Activity With Brain Volume

Dose-Response Association Between Physical Activity (Daily MIMS, Peak 30-Minute MIMS) and Cognitive Function Among Older Adults: NHANES 2011-2014

Physical activity and cognitive function in multiple sclerosis.

The Relationship Between Activity Level and Cognitive Function in Chinese Community-Dwelling Elderly

Associations between physical activity, sedentary behaviour and cognitive domain performance of people living with mild cognitive impairment in the community

Comparison of patient-reported outcomes of physical activity and accelerometry in people with multiple sclerosis and ambulatory impairment: a cross-sectional study

Information processing speed and disease severity predict real-world ambulation in persons with multiple sclerosis

Review: ziprasidone is marginally less effective than other atypical antipsychotics in people with schizophrenia

Advances in noninvasive screening for renovascular disease.

CT and MR imaging of primary cardiac malignancies.

Association between changes in habitual stepping activity and cognition in older adults

Exploring the Association Between Physical Activity and Cognitive Function Among People Living with Dementia